Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Personality disorder? 234 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 234 reports of Personality disorder have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.3% of all adverse event reports for ESOMEPRAZOLE.

234
Reports of Personality disorder with ESOMEPRAZOLE
0.3%
of all ESOMEPRAZOLE reports
0
Deaths
223
Hospitalizations

How Dangerous Is Personality disorder From ESOMEPRAZOLE?

Of the 234 reports, 223 (95.3%) required hospitalization, and 203 (86.8%) were considered life-threatening.

Is Personality disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 234 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Personality disorder?

METFORMIN (270) AMLODIPINE (264) IRBESARTAN (256) ATORVASTATIN (248) SITAGLIPTIN (245) ASPIRIN (209) MORPHINE (190) ALISKIREN HEMIFUMARATE (181) ACETAMINOPHEN (169) ALISKIREN (160)

Which ESOMEPRAZOLE Alternatives Have Lower Personality disorder Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Personality disorder Reports All Drugs Causing Personality disorder ESOMEPRAZOLE Demographics